Ozempic and unintended pregnancy: what the 'Ozempic babies' trend gets right and wrong
Quick answer
Semaglutide (Ozempic, Wegovy) can improve ovulatory function in women with PCOS through weight-loss-mediated hormonal normalization, which may explain increased unintended pregnancies in this population. The drug theoretically reduces oral contraceptive absorption via delayed gastric emptying, but clinical data confirming meaningful contraceptive failure rates from this mechanism are lacking. Semaglutide is not approved in pregnancy and should be discontinued at least two months prior to conception, ideally with a provider-managed transition plan.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @dr.notms actually say?
The creator claimed that semaglutide (Ozempic) may interact with hormonal birth control, that weight loss from the drug can improve fertility especially in women with PCOS, and that anyone not trying to get pregnant should add barrier protection on top of existing contraception. They also stated that people who are pregnant should "stop immediately." These are the core claims worth examining.
To their credit, they acknowledged the evidence is not settled, saying "we still need more studies." That caveat matters. But the video still presents a fairly confident clinical recommendation, complete with a plug for a telehealth discovery call, which is worth keeping in mind when evaluating how this information is packaged and delivered.
Does the science back this up?
Partially, yes. The fertility angle for PCOS patients is the strongest part of this video. The birth control interference claim is plausible but still speculative, and the "stop immediately if pregnant" advice is directionally right but too blunt.
On PCOS: weight loss consistently improves hormonal profiles in women with PCOS, restoring ovulation in women who previously had irregular cycles. A 2019 meta-analysis by Lim et al. in Human Reproduction Update confirmed that even modest weight loss (5-10%) significantly improved ovulation rates and pregnancy outcomes in overweight women with PCOS. Semaglutide, by driving that weight loss, could plausibly contribute to this effect.
On birth control interference: the mechanism proposed is that GLP-1 receptor agonists slow gastric emptying, which could theoretically reduce absorption of oral contraceptives. This is biologically plausible. Novo Nordisk's prescribing information for Ozempic does note a potential interaction with oral medications due to delayed gastric emptying. However, a 2022 pharmacokinetic study by Hausner et al. in Clinical Pharmacokinetics found that semaglutide had a relatively small effect on oral contraceptive exposure, and its clinical significance remains uncertain. The creator overstates certainty here.
What did they get wrong (or right)?
They got the PCOS-fertility connection right. That link is well-supported and relevant to the audience asking why people are getting pregnant on Ozempic. Credit where it is due.
What they got wrong, or at least imprecise: the birth control interference claim is presented as a likely mechanism when the clinical evidence is thin. Saying researchers "think" Ozempic may be interacting with birth control methods is accurate as a description of a hypothesis, but the way it lands in a short TikTok video is that this is an established risk. It is not.
The "stop immediately if pregnant" advice is also more complicated than presented. The FDA advises discontinuing semaglutide during pregnancy, yes. But "stop immediately" without mentioning the need to consult a provider first is the kind of oversimplification that can cause harm, especially for patients managing type 2 diabetes who may need a transition plan.
Finally, the creator is a telehealth provider with a call-to-action embedded in this video. That does not make the information wrong, but it is worth noting that the recommendation to add barrier protection is framed as clinical advice delivered without a full patient history.
What should you actually know?
If you are using hormonal birth control and taking a GLP-1 medication, talk to your prescriber. The theoretical interaction with oral contraceptives exists in the pharmacology, but it has not been shown to cause a clinically meaningful increase in unintended pregnancies in large studies. The "Ozempic babies" phenomenon is more likely explained by restored ovulation in women with PCOS or obesity-related anovulation than by birth control failure.
If you are pregnant or planning to become pregnant, GLP-1 receptor agonists are not approved for use during pregnancy. The current recommendation from the FDA and most clinical guidelines is to discontinue these medications at least two months before a planned pregnancy. Animal studies have shown fetal harm at high doses, though human data is limited. Do not stop or start any medication during pregnancy without speaking to your OB or prescriber first.
The broader takeaway: semaglutide's effects on fertility are real but are mostly indirect, driven by weight loss and hormonal normalization rather than any direct action on reproductive tissue. This is a plausible and interesting area of ongoing research, not a settled fertility treatment.
Bottom line
This video is not misinformation, but it is imprecise in ways that matter. The PCOS and fertility connection is solid. The birth control interference claim is speculative. The clinical recommendations are directionally reasonable but lack the nuance a patient deserves. If your TikTok feed is your primary source of reproductive health guidance, that is the bigger problem to solve.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Ozempic and unintended pregnancy: what the 'Ozempic babies' trend gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Claim verdict
The useful answer behind this video
Claim being checked
Semaglutide (Ozempic, Wegovy) can improve ovulatory function in women with PCOS through weight-loss-mediated hormonal normalization, which may explain increased unintended pregnancies in this population.
FormBlends verdict
Semaglutide (Ozempic, Wegovy) can improve ovulatory function in women with PCOS through weight-loss-mediated hormonal normalization, which may explain increased unintended pregnancies in this population. The drug theoretically reduces oral contraceptive absorption via delayed gastric emptying, but clinical data confirming meaningful contraceptive failure rates from this mechanism are lacking. Semaglutide is not approved in pregnancy and should be discontinued at least two months prior to conception, ideally with a provider-managed transition plan.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Semaglutide (Ozempic, Wegovy) can improve ovulatory function in women with PCOS through weight-loss-mediated hormonal normalization, which may explain increased unintended pregnancies in this population. The drug theoretically reduces oral contraceptive absorption via delayed gastric emptying, but clinical data confirming meaningful contraceptive failure rates from this mechanism are lacking. Semaglutide is not approved in pregnancy and should be discontinued at least two months prior to conception, ideally with a provider-managed transition plan.
- A 2019 meta-analysis (Lim et al., Human Reproduction Update) found that 5-10% weight loss restores ovulation in a meaningful proportion of overweight women with PCOS, which is the most evidence-supported explanation for increased pregnancies among Ozempic users.
- Novo Nordisk's prescribing information acknowledges that semaglutide may reduce absorption of oral medications due to delayed gastric emptying, but no large clinical trial has confirmed this causes oral contraceptive failure at a meaningful rate.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- A 2019 meta-analysis (Lim et al., Human Reproduction Update) found that 5-10% weight loss restores ovulation in a meaningful proportion of overweight women with PCOS, which is the most evidence-supported explanation for increased pregnancies among Ozempic users.
- Novo Nordisk's prescribing information acknowledges that semaglutide may reduce absorption of oral medications due to delayed gastric emptying, but no large clinical trial has confirmed this causes oral contraceptive failure at a meaningful rate.
- The FDA recommends discontinuing semaglutide before pregnancy. Current clinical guidelines from ACOG suggest stopping at least two months before a planned conception.
- Animal reproduction studies with semaglutide showed fetal harm at doses above human therapeutic range. Human pregnancy safety data remains limited as of 2024.
- The 'Ozempic babies' effect is most likely driven by restored ovulation in women with PCOS or obesity-related anovulation, not by birth control failure from drug interaction.
- Adding barrier contraception as a backup for oral contraceptive users on GLP-1 medications is a reasonable precaution given the theoretical interaction, but it should be discussed with a prescriber rather than adopted based on a TikTok recommendation.
- Semaglutide is not approved as a fertility treatment. Any patient hoping to use it for that purpose should have a full evaluation by a reproductive endocrinologist.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Gabwilliamsmd · TikTok creator
2.7K views on this video
They just keep finding more and more effects of Ozempic… Ya’ll be safe out there. This is the second reason to put on a condom- catch the live @drnylander and I did on Tuesday to learn the first reason! #ozempicbabies #weightloss #primarycare
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Gabwilliamsmd, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.